Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection

被引:0
作者
Susana Fuentes
Els van Nood
Sebastian Tims
Ineke Heikamp-de Jong
Cajo JF ter Braak
Josbert J Keller
Erwin G Zoetendal
Willem M de Vos
机构
[1] Laboratory of Microbiology,Department of Internal Medicine
[2] Wageningen University,Department of Gastroenterology
[3] Academic Medical Center,Departments of Bacteriology and Immunology
[4] University of Amsterdam,undefined
[5] Biometris,undefined
[6] Wageningen University,undefined
[7] Haga teaching hospital,undefined
[8] and Veterinary Biosciences,undefined
[9] University of Helsinki,undefined
来源
The ISME Journal | 2014年 / 8卷
关键词
faecal microbiota transplantation; infection; HITChip; intestinal microbiota;
D O I
暂无
中图分类号
学科分类号
摘要
Recurrent Clostridium difficile infection (CDI) can be effectively treated by infusion of a healthy donor faeces suspension. However, it is unclear what factors determine treatment efficacy. By using a phylogenetic microarray platform, we assessed composition, diversity and dynamics of faecal microbiota before, after and during follow-up of the transplantation from a healthy donor to different patients, to elucidate the mechanism of action of faecal infusion. Global composition and network analysis of the microbiota was performed in faecal samples from nine patients with recurrent CDI. Analyses were performed before and after duodenal donor faeces infusion, and during a follow-up of 10 weeks. The microbiota data were compared with that of the healthy donors. All patients successfully recovered. Their intestinal microbiota changed from a low-diversity diseased state, dominated by Proteobacteria and Bacilli, to a more diverse ecosystem resembling that of healthy donors, dominated by Bacteroidetes and Clostridium groups, including butyrate-producing bacteria. We identified specific multi-species networks and signature microbial groups that were either depleted or restored as a result of the treatment. The changes persisted over time. Comprehensive and deep analyses of the microbiota of patients before and after treatment exposed a therapeutic reset from a diseased state towards a healthy profile. The identification of microbial groups that constitute a niche for C. difficile overgrowth, as well as those driving the reinstallation of a healthy intestinal microbiota, could contribute to the development of biomarkers predicting recurrence and treatment outcome, identifying an optimal microbiota composition that could lead to targeted treatment strategies.
引用
收藏
页码:1621 / 1633
页数:12
相关论文
共 256 条
[1]  
Ananthakrishnan AN(2009) and inflammatory bowel disease Gastroenterol Clin North Am 38 711-728
[2]  
Issa M(2013)Intestinal dysbiosis and depletion of butyrogenic bacteria in J Clin Microbiol 51 2884-2892
[3]  
Binion DG(2011) infection and nosocomial diarrhea Nature 473 174-180
[4]  
Antharam VC(2013)Enterotypes of the human gut microbiome Neurogastroenterol Motil 25 4-15
[5]  
Li EC(2011)Gut microbiota and gastrointestinal health: current concepts and future directions Clin Gastroenterol Hepatol 9 1044-1049
[6]  
Ishmael A(2011)Treating Nat Rev Gastroenterol Hepatol 9 88-96
[7]  
Sharma A(2003) infection with fecal microbiota transplantation J Clin Gastroenterol 37 42-47
[8]  
Mai V(2011)Fecal microbiota transplantation and emerging applications J Clin Gastroenterol 45 655-657
[9]  
Rand KH(2008)Treatment of ulcerative colitis using fecal bacteriotherapy J Infect Dis 197 435-438
[10]  
Arumugam M(2013)Endoscopic fecal microbiota transplantation: ‘first-line’ treatment for severe Microbiol Biotechnol 6 316-325